JMDC: FY2024 Q2 Financial Briefing Material
JMDC: Summary of Financial Statements for the Six Months Ended September 30, 2024 [IFRS] (Consolidated)
JMDC: Kurashiki Central Hospital and JMDC Group begin joint research aimed at generating evidence to contribute to public applications for non-indicated pediatric drugs using an electronic medical record database
JMDC: Notice of Confirmed Details of Share Subscription Rights (Stock Options Offered for Value)
JMDC: Announcement regarding the issuance of subscription rights (stock options based on value)
JMDC: Summary of consolidated financial statements [IFRS] for the three months ending on June 30, 2024.
JMDC: Financial presentation materials for the first quarter of fiscal year 2024.
JMDC: Lear world data, in collaboration with Eisai, conducted a post-marketing database survey using additional data collection.
JMDC: Corporate Governance Report
JMDC: Bylaws 25th June 2024
JMDC: Notification regarding compliance with the maintenance criteria for listings.
JMDC: Plan for compliance with listing maintenance standards
JMDC: Notice regarding matters related to dominant shareholders.
JMDC: Regarding matters related to dominant shareholders.
JMDC: Independent Officer Notification Form
JMDC: Notice of partial amendments to the Articles of Incorporation
JMDC: Notice regarding partial changes to the Articles of Incorporation
JMDC: Notice regarding the change of representative director
JMDC: Notice regarding dividends from surplus funds
JMDC: Summary of financial statements for the fiscal year ended 2024/3/31 [IFRS] (consolidated)
No Data
No Data